164 related articles for article (PubMed ID: 33902648)
1. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma.
Abbaszadegan MR; Taghehchian N; Aarabi A; Akbari F; Saburi E; Moghbeli M
Diagn Pathol; 2021 Apr; 16(1):36. PubMed ID: 33902648
[TBL] [Abstract][Full Text] [Related]
2. Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.
Li P; Chen X; Qin G; Yue D; Zhang Z; Ping Y; Wang D; Zhao X; Song M; Zhao Q; Li J; Liu S; Wang D; Zhang C; Lian J; Cao L; Li F; Huang L; Wang L; Yang L; Huang J; Li H; Zhang B; Zhang Y
Cancer Immunol Res; 2018 Oct; 6(10):1246-1259. PubMed ID: 30082413
[No Abstract] [Full Text] [Related]
3. MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection.
Abbaszadegan MR; Taghehchian N; Aarabi A; Moghbeli M
J Gastrointest Cancer; 2020 Mar; 51(1):17-22. PubMed ID: 30488287
[TBL] [Abstract][Full Text] [Related]
4. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
5. Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.
Hashemi Bidokhti M; Abbaszadegan MR; Sharifi N; Abbasi Sani S; Forghanifard MM
Ann Diagn Pathol; 2017 Apr; 27():79-82. PubMed ID: 28325367
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
8. Genetic and molecular bases of esophageal Cancer among Iranians: an update.
Abbaszadegan MR; Keyvani V; Moghbeli M
Diagn Pathol; 2019 Aug; 14(1):97. PubMed ID: 31470870
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
11. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
12. A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma.
Dadkhah E; Naseh H; Farshchian M; Memar B; Sankian M; Bagheri R; Forghanifard MM; Montazer M; Kazemi Noughabi M; Hashemi M; Abbaszadegan MR
Arch Iran Med; 2013 Aug; 16(8):463-70. PubMed ID: 23906251
[TBL] [Abstract][Full Text] [Related]
13. High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.
Liu Z; Ma C; Ma G; Sun X; Liu J; Li S; Liu K; Wang J; Yang D
Hum Pathol; 2018 Oct; 80():179-185. PubMed ID: 29920311
[TBL] [Abstract][Full Text] [Related]
14. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances.
Mou X; Peng Z; Yin T; Sun X
J Gastrointest Cancer; 2024 Mar; 55(1):118-128. PubMed ID: 37924487
[TBL] [Abstract][Full Text] [Related]
15. Role of DIDO1 in Progression of Esophageal Squamous Cell Carcinoma.
Forghanifard MM; Naeimi Khorasanizadeh P; Abbaszadegan MR; Javdani Mallak A; Moghbeli M
J Gastrointest Cancer; 2020 Mar; 51(1):83-87. PubMed ID: 30761474
[TBL] [Abstract][Full Text] [Related]
16. Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.
Abbaszadegan MR; Moghbeli M
Pathol Oncol Res; 2018 Apr; 24(2):245-250. PubMed ID: 28462489
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
[TBL] [Abstract][Full Text] [Related]
19. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
